The DOI matches its Crossref record; 91 of the 91 references it cites were found in a registry or an index.
Transthyretin Amyloid Cardiomyopathy
Open accessAbstract
Transthyretin amyloid cardiomyopathy (ATTR-CM) is an under-recognized cause of heart failure (HF) in older adults, resulting from myocardial deposition of misfolded transthyretin (TTR or prealbumin). Characteristic patterns of echocardiography and cardiac magnetic resonance imaging are strongly suggestive but not diagnostic. The diagnosis can be made with non-invasive nuclear imaging when there is no evidence of a monoclonal protein. Amyloid fibril formation results from a destabilizing mutation in hereditary ATTR amyloidosis (hATTR) or from an aging-linked process in wild-type ATTR amyloidosis (wtATTR). Recent studies suggest that up to 10–15% of older adults with HF may harbor unrecognized wtATTR. Associated features, including carpal tunnel syndrome and lumbar spinal stenosis, raise suspicion and may afford a means for early diagnosis. Previously treatable only by organ transplantation, pharmaceutical therapy that slows or halts ATTR-CM progression and favorably affects clinical outcomes is now available. Early recognition remains essential to afford the best treatment efficacy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis
Adams, D., Gonzalez-Duarte, A., O’Riordan, W. D., Yang, C.-C., Ueda, M., Kristen, A. V., Tournev, I., Schmidt, H. H., Coelho, T., Berk, J. L., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1716153 · Cited by 3,047
Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy
Maurer, M. S., Schwartz, J. H., Gundapaneni, B., Elliott, P. M., Merlini, G., Waddington-Cruz, M., Kristen, A. V., Grogan, M., Witteles, R., Damy, T., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1805689 · Cited by 2,857
Self-citationACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities
Epstein, A. E., DiMarco, J. P., Ellenbogen, K. A., Estes, N. A. M., Freedman, R. A., Gettes, L. S., Gillinov, A. M., Gregoratos, G., Hammill, S. C., Hayes, D. L., et al. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.02.032 · Cited by 2,546
Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis
Gillmore, J. D., Maurer, M. S., Falk, R. H., Merlini, G., Damy, T., Dispenzieri, A., Wechalekar, A. D., Berk, J. L., Quarta, C. C., Grogan, M., et al. (2016) · Circulation · doi:10.1161/circulationaha.116.021612 · Cited by 2,081
Self-citationInotersen Treatment for Patients with Hereditary Transthyretin Amyloidosis
Benson, M. D., Waddington-Cruz, M., Berk, J. L., Polydefkis, M., Dyck, P. J., Wang, A. K., Planté-Bordeneuve, V., Barroso, F. A., Merlini, G., Obici, L., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1716793 · Cited by 1,452
Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction
González-López, E., Gallego-Delgado, M., Guzzo-Merello, G., de Haro-del Moral, F. J., Cobo-Marcos, M., Robles, C., Bornstein, B., Salas, C., Lara-Pezzi, E., Alonso-Pulpon, L., et al. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv338 · Cited by 1,174
Wechalekar, A. D., Gillmore, J. D., & Hawkins, P. N. (2016) · The Lancet · doi:10.1016/s0140-6736(15)01274-x · Cited by 994
Perugini, E., Guidalotti, P. L., Salvi, F., Cooke, R. M. T., Pettinato, C., Riva, L., Leone, O., Farsad, M., Ciliberti, P., Bacchi-Reggiani, L., et al. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.05.073 · Cited by 981
Vrana, J. A., Gamez, J. D., Madden, B. J., Theis, J. D., Bergen, H. R., & Dogan, A. (2009) · Blood · doi:10.1182/blood-2009-07-230722 · Cited by 904
Tafamidis for transthyretin familial amyloid polyneuropathy: A randomized, controlled trial
Coelho, T., Maia, L. F., Martins da Silva, A., Waddington Cruz, M., Planté-Bordeneuve, V., Lozeron, P., Suhr, O. B., Campistol, J. M., Conceição, I. M., Schmidt, H. H.-J., et al. (2012) · Neurology · doi:10.1212/wnl.0b013e3182661eb1 · Cited by 816
Self-citationA new staging system for cardiac transthyretin amyloidosis
Gillmore, J. D., Damy, T., Fontana, M., Hutchinson, M., Lachmann, H. J., Martinez-Naharro, A., Quarta, C. C., Rezk, T., Whelan, C. J., Gonzalez-Lopez, E., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehx589 · Cited by 776
Systemic Cardiac Amyloidoses: Disease Profiles and Clinical Courses of the 3 Main Types
Rapezzi, C., Merlini, G., Quarta, C. C., Riva, L., Longhi, S., Leone, O., Salvi, F., Ciliberti, P., Pastorelli, F., Biagini, E., et al. (2009) · Circulation · doi:10.1161/circulationaha.108.843334 · Cited by 774
Grogan, M., Scott, C. G., Kyle, R. A., Zeldenrust, S. R., Gertz, M. A., Lin, G., Klarich, K. W., Miller, W. L., Maleszewski, J. J., & Dispenzieri, A. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.06.033 · Cited by 763
Self-citationCastaño, A., Narotsky, D. L., Hamid, N., Khalique, O. K., Morgenstern, R., DeLuca, A., Rubin, J., Chiuzan, C., Nazif, T., Vahl, T., et al. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehx350 · Cited by 726
Self-citationTransthyretin (TTR) Cardiac Amyloidosis
Ruberg, F. L., & Berk, J. L. (2012) · Circulation · doi:10.1161/circulationaha.111.078915 · Cited by 708
Self-citationRepurposing Diflunisal for Familial Amyloid Polyneuropathy: A Randomized Clinical Trial
Berk, J. L., Suhr, O. B., Obici, L., Sekijima, Y., Zeldenrust, S. R., Yamashita, T., Heneghan, M. A., Gorevic, P. D., Litchy, W. J., Wiesman, J. F., et al. (2013) · JAMA · doi:10.1001/jama.2013.283815 · Cited by 708
Self-citationFibril in senile systemic amyloidosis is derived from normal transthyretin.
Westermark, P., Sletten, K., Johansson, B., & Cornwell, G. G. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.7.2843 · Cited by 696
Kyle, R., Linos, A., Beard, C., Linke, R., Gertz, M., O'Fallon, W., & Kurland, L. (1992) · Blood · doi:10.1182/blood.v79.7.1817.1817 · Cited by 657
AL (Light-Chain) Cardiac Amyloidosis
Falk, R. H., Alexander, K. M., Liao, R., & Dorbala, S. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.06.053 · Cited by 649
Bokhari, S., Castaño, A., Pozniakoff, T., Deslisle, S., Latif, F., & Maurer, M. S. (2013) · Circulation: Cardiovascular Imaging · doi:10.1161/circimaging.112.000132 · Cited by 622
Self-citationTanskanen, M., Peuralinna, T., Polvikoski, T., Notkola, I., Sulkava, R., Hardy, J., Singleton, A., Kiuru‐Enari, S., Paetau, A., Tienari, P. J., et al. (2008) · Annals of Medicine · doi:10.1080/07853890701842988 · Cited by 591
Role of Cardiac Magnetic Resonance Imaging in the Detection of Cardiac Amyloidosis
Syed, I. S., Glockner, J. F., Feng, D., Araoz, P. A., Martinez, M. W., Edwards, W. D., Gertz, M. A., Dispenzieri, A., Oh, J. K., Bellavia, D., et al. (2010) · JACC: Cardiovascular Imaging · doi:10.1016/j.jcmg.2009.09.023 · Cited by 545
Self-citationGenotype and Phenotype of Transthyretin Cardiac Amyloidosis
Maurer, M. S., Hanna, M., Grogan, M., Dispenzieri, A., Witteles, R., Drachman, B., Judge, D. P., Lenihan, D. J., Gottlieb, S. S., Shah, S. J., et al. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.03.596 · Cited by 538
Self-citationFrequency and distribution of senile cardiovascular amyloid
Cornwell, G. G., Murdoch, W. L., Kyle, R. A., Westermark, P., & Pitkänen, P. (1983) · The American Journal of Medicine · doi:10.1016/0002-9343(83)90443-6 · Cited by 483
Solomon, S. D., Adams, D., Kristen, A., Grogan, M., González-Duarte, A., Maurer, M. S., Merlini, G., Damy, T., Slama, M. S., Brannagan, T. H., et al. (2019) · Circulation · doi:10.1161/circulationaha.118.035831 · Cited by 462
Self-citationLeft Ventricular Amyloid Deposition in Patients With Heart Failure and Preserved Ejection Fraction
Mohammed, S. F., Mirzoyev, S. A., Edwards, W. D., Dogan, A., Grogan, D. R., Dunlay, S. M., Roger, V. L., Gertz, M. A., Dispenzieri, A., Zeldenrust, S. R., et al. (2014) · JACC: Heart Failure · doi:10.1016/j.jchf.2013.11.004 · Cited by 448
Magnetic Resonance in Transthyretin Cardiac Amyloidosis
Martinez-Naharro, A., Treibel, T. A., Abdel-Gadir, A., Bulluck, H., Zumbo, G., Knight, D. S., Kotecha, T., Francis, R., Hutt, D. F., Rezk, T., et al. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.05.053 · Cited by 437
Castano, A., Haq, M., Narotsky, D. L., Goldsmith, J., Weinberg, R. L., Morgenstern, R., Pozniakoff, T., Ruberg, F. L., Miller, E. J., Berk, J. L., et al. (2016) · JAMA Cardiology · doi:10.1001/jamacardio.2016.2839 · Cited by 424
Self-citationEpidemiology of AL amyloidosis: a real-world study using US claims data
Quock, T. P., Yan, T., Chang, E., Guthrie, S., & Broder, M. S. (2018) · Blood Advances · doi:10.1182/bloodadvances.2018016402 · Cited by 416
Therapeutic Clearance of Amyloid by Antibodies to Serum Amyloid P Component
Richards, D. B., Cookson, L. M., Berges, A. C., Barton, S. V., Lane, T., Ritter, J. M., Fontana, M., Moon, J. C., Pinzani, M., Gillmore, J. D., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1504942 · Cited by 378
Clinical characteristics of wild-type transthyretin cardiac amyloidosis: disproving myths
González-López, E., Gagliardi, C., Dominguez, F., Quarta, C. C., de Haro-del Moral, F. J., Milandri, A., Salas, C., Cinelli, M., Cobo-Marcos, M., Lorenzini, M., et al. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehx043 · Cited by 376
Senile Systemic Amyloidosis: Clinical Features at Presentation and Outcome
Pinney, J. H., Whelan, C. J., Petrie, A., Dungu, J., Banypersad, S. M., Sattianayagam, P., Wechalekar, A., Gibbs, S. D. J., Venner, C. P., Wassef, N., et al. (2013) · Journal of the American Heart Association · doi:10.1161/jaha.113.000098 · Cited by 372
Combining mortality and longitudinal measures in clinical trials
Finkelstein, D. M., & Schoenfeld, D. A. (1999) · Statistics in Medicine · doi:10.1002/(sici)1097-0258(19990615)18:11<1341::aid-sim129>3.0.co;2-7 · Cited by 363
Tenosynovial and Cardiac Amyloidosis in Patients Undergoing Carpal Tunnel Release
Sperry, B. W., Reyes, B. A., Ikram, A., Donnelly, J. P., Phelan, D., Jaber, W. A., Shapiro, D., Evans, P. J., Maschke, S., Kilpatrick, S. E., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.07.092 · Cited by 358
Self-citationQuarta, C. C., Solomon, S. D., Uraizee, I., Kruger, J., Longhi, S., Ferlito, M., Gagliardi, C., Milandri, A., Rapezzi, C., & Falk, R. H. (2014) · Circulation · doi:10.1161/circulationaha.113.006242 · Cited by 345
CMR-Based Differentiation of AL and ATTR Cardiac Amyloidosis
Dungu, J. N., Valencia, O., Pinney, J. H., Gibbs, S. D. J., Rowczenio, D., Gilbertson, J. A., Lachmann, H. J., Wechalekar, A., Gillmore, J. D., Whelan, C. J., et al. (2014) · JACC: Cardiovascular Imaging · doi:10.1016/j.jcmg.2013.08.015 · Cited by 344
Muchtar, E., Gertz, M. A., Kumar, S. K., Lacy, M. Q., Dingli, D., Buadi, F. K., Grogan, M., Hayman, S. R., Kapoor, P., Leung, N., et al. (2017) · Blood · doi:10.1182/blood-2016-11-751628 · Cited by 340
Self-citationRapezzi, C., Quarta, C. C., Guidalotti, P. L., Pettinato, C., Fanti, S., Leone, O., Ferlini, A., Longhi, S., Lorenzini, M., Reggiani, L. B., et al. (2011) · JACC: Cardiovascular Imaging · doi:10.1016/j.jcmg.2011.03.016 · Cited by 331
Connors, L. H., Sam, F., Skinner, M., Salinaro, F., Sun, F., Ruberg, F. L., Berk, J. L., & Seldin, D. C. (2016) · Circulation · doi:10.1161/circulationaha.115.018852 · Cited by 324
Self-citationSuhr, O. B., Coelho, T., Buades, J., Pouget, J., Conceicao, I., Berk, J., Schmidt, H., Waddington-Cruz, M., Campistol, J. M., Bettencourt, B. R., et al. (2015) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-015-0326-6 · Cited by 321 · cited 1×
“Phase I and Phase II studies of patisiran in healthy volunteers and in patients with hATTR polyneuropathy showed a dose dependent and robust mean reduction in serum TTR levels of up to 90%(90).”
BackgroundTreibel, T. A., Fontana, M., Gilbertson, J. A., Castelletti, S., White, S. K., Scully, P. R., Roberts, N., Hutt, D. F., Rowczenio, D. M., Whelan, C. J., et al. (2016) · Circulation: Cardiovascular Imaging · doi:10.1161/circimaging.116.005066 · Cited by 317
Pagourelias, E. D., Mirea, O., Duchenne, J., Van Cleemput, J., Delforge, M., Bogaert, J., Kuznetsova, T., & Voigt, J.-U. (2017) · Circulation: Cardiovascular Imaging · doi:10.1161/circimaging.116.005588 · Cited by 306
Intracardiac Thrombosis and Embolism in Patients With Cardiac Amyloidosis
Feng, D., Edwards, W. D., Oh, J. K., Chandrasekaran, K., Grogan, M., Martinez, M. W., Syed, I. I., Hughes, D. A., Lust, J. A., Jaffe, A. S., et al. (2007) · Circulation · doi:10.1161/circulationaha.107.697763 · Cited by 305
Self-citationThe Amyloidogenic V122I Transthyretin Variant in Elderly Black Americans
Quarta, C. C., Buxbaum, J. N., Shah, A. M., Falk, R. H., Claggett, B., Kitzman, D. W., Mosley, T. H., Butler, K. R., Boerwinkle, E., & Solomon, S. D. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1404852 · Cited by 263
Transthyretin Stabilization by AG10 in Symptomatic Transthyretin Amyloid Cardiomyopathy
Judge, D. P., Heitner, S. B., Falk, R. H., Maurer, M. S., Shah, S. J., Witteles, R. M., Grogan, M., Selby, V. N., Jacoby, D., Hanna, M., et al. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.03.012 · Cited by 263
Self-citationRuberg, F. L., Maurer, M. S., Judge, D. P., Zeldenrust, S., Skinner, M., Kim, A. Y., Falk, R. H., Cheung, K. N., Patel, A. R., Pano, A., et al. (2012) · American Heart Journal · doi:10.1016/j.ahj.2012.04.015 · Cited by 261
Self-citationDamy, T., Costes, B., Hagège, A. A., Donal, E., Eicher, J.-C., Slama, M., Guellich, A., Rappeneau, S., Gueffet, J.-P., Logeart, D., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehv583 · Cited by 247
Diagnostic sensitivity of abdominal fat aspiration in cardiac amyloidosis
Quarta, C. C., Gonzalez-Lopez, E., Gilbertson, J. A., Botcher, N., Rowczenio, D., Petrie, A., Rezk, T., Youngstein, T., Mahmood, S., Sachchithanantham, S., et al. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehx047 · Cited by 227
Carpal tunnel syndrome: a common initial symptom of systemic wild-type ATTR (ATTRwt) amyloidosis
Nakagawa, M., Sekijima, Y., Yazaki, M., Tojo, K., Yoshinaga, T., Doden, T., Koyama, J., Yanagisawa, S., & Ikeda, S.-I. (2016) · Amyloid · doi:10.3109/13506129.2015.1135792 · Cited by 226
Cardiac amyloidosis is prevalent in older patients with aortic stenosis and carries worse prognosis
Cavalcante, J. L., Rijal, S., Abdelkarim, I., Althouse, A. D., Sharbaugh, M. S., Fridman, Y., Soman, P., Forman, D. E., Schindler, J. T., Gleason, T. G., et al. (2016) · Journal of Cardiovascular Magnetic Resonance · doi:10.1186/s12968-017-0415-x · Cited by 220
Cardiac amyloidosis: An update on diagnosis and treatment
Donnelly, J. P., & Hanna, M. (2017) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.84.s3.02 · Cited by 213
Self-citationTransthyretin Quaternary and Tertiary Structural Changes Facilitate Misassembly into Amyloid
KELLY, J., COLON, W., LAI, Z., LASHUEL, H., MCCULLOCH, J., MCCUTCHEN, S., MIROY, G., & PETERSON, S. (1997) · Advances in Protein Chemistry · doi:10.1016/s0065-3233(08)60321-6 · Cited by 204
Self-citationDirect Current Cardioversion of Atrial Arrhythmias in Adults With Cardiac Amyloidosis
El-Am, E. A., Dispenzieri, A., Melduni, R. M., Ammash, N. M., White, R. D., Hodge, D. O., Noseworthy, P. A., Lin, G., Pislaru, S. V., Egbe, A. C., et al. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.10.079 · Cited by 202
Self-citationPenchala, S. C., Connelly, S., Wang, Y., Park, M. S., Zhao, L., Baranczak, A., Rappley, I., Vogel, H., Liedtke, M., Witteles, R. M., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1300761110 · Cited by 198
Self-citationAssociation Between Ruptured Distal Biceps Tendon and Wild-Type Transthyretin Cardiac Amyloidosis
Geller, H. I., Singh, A., Alexander, K. M., Mirto, T. M., & Falk, R. H. (2017) · JAMA · doi:10.1001/jama.2017.9236 · Cited by 190
Implantable Cardioverter Defibrillators in Patients with Cardiac Amyloidosis
LIN, G., DISPENZIERI, A., KYLE, R., GROGAN, M., & BRADY, P. A. (2013) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.12123 · Cited by 188
Self-citationBuxbaum, J. N., & Ruberg, F. L. (2017) · Genetics in Medicine · doi:10.1038/gim.2016.200 · Cited by 178
Self-citationSant'Anna, R., Gallego, P., Robinson, L. Z., Pereira-Henriques, A., Ferreira, N., Pinheiro, F., Esperante, S., Pallares, I., Huertas, O., Rosário Almeida, M., et al. (2016) · Nature Communications · doi:10.1038/ncomms10787 · Cited by 177
Lilleness, B., Ruberg, F. L., Mussinelli, R., Doros, G. D., & Sanchorawala, V. (2018) · Blood · doi:10.1182/blood-2018-06-858951 · Cited by 175
Self-citation11C-Pittsburgh B PET Imaging in Cardiac Amyloidosis
Lee, S.-P., Lee, E. S., Choi, H., Im, H.-J., Koh, Y., Lee, M.-H., Kwon, J.-H., Paeng, J. C., Kim, H.-K., Cheon, G. J., et al. (2015) · JACC: Cardiovascular Imaging · doi:10.1016/j.jcmg.2014.09.018 · Cited by 171
Jiang, X., Buxbaum, J. N., & Kelly, J. W. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.261419998 · Cited by 166
Self-citationA study of implanted cardiac rhythm recorders in advanced cardiac AL amyloidosis
Sayed, R. H., Rogers, D., Khan, F., Wechalekar, A. D., Lachmann, H. J., Fontana, M., Mahmood, S., Sachchithanantham, S., Patel, K., Hawkins, P. N., et al. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehu506 · Cited by 165
Monoclonal gammopathy of undetermined significance in systemic transthyretin amyloidosis (ATTR)
Phull, P., Sanchorawala, V., Connors, L. H., Doros, G., Ruberg, F. L., Berk, J. L., & Sarosiek, S. (2018) · Amyloid · doi:10.1080/13506129.2018.1436048 · Cited by 165
Self-citationTransthyretin-derived amyloidosis: Probably a common cause of lumbar spinal stenosis
Westermark, P., Westermark, G. T., Suhr, O. B., & Berg, S. (2014) · Upsala Journal of Medical Sciences · doi:10.3109/03009734.2014.895786 · Cited by 164
Yanagisawa, A., Ueda, M., Sueyoshi, T., Okada, T., Fujimoto, T., Ogi, Y., Kitagawa, K., Tasaki, M., Misumi, Y., Oshima, T., et al. (2015) · Modern Pathology · doi:10.1038/modpathol.2014.102 · Cited by 161
Zhao, L., Tian, Z., & Fang, Q. (2016) · BMC Cardiovascular Disorders · doi:10.1186/s12872-016-0311-6 · Cited by 160
Endomyocardial Biopsy in 30 Patients With Primary Amyloidosis and Suspected Cardiac Involvement
Pellikka, P. A. (1988) · Archives of Internal Medicine · doi:10.1001/archinte.148.3.662 · Cited by 159
Diflunisal for ATTR Cardiac Amyloidosis
Castaño, A., Helmke, S. T., Alvarez, J., Delisle, S., & Maurer, M. S. (2012) · Congestive Heart Failure · doi:10.1111/j.1751-7133.2012.00303.x · Cited by 156
Self-citationMaurer, M. S., Grogan, D. R., Judge, D. P., Mundayat, R., Packman, J., Lombardo, I., Quyyumi, A. A., Aarts, J. M., & Falk, R. H. (2015) · Circulation Heart Failure · doi:10.1161/circheartfailure.113.000890 · Cited by 156
Self-citationImplantable cardioverter-defibrillator placement in patients with cardiac amyloidosis
Varr, B. C., Zarafshar, S., Coakley, T. R., Liedtke, M., Lafayette, R. A., Arai, S., Schrier, S. L., & Witteles, R. M. (2013) · Heart Rhythm · doi:10.1016/j.hrthm.2013.10.026 · Cited by 156
Stats, M. A., & Stone, J. R. (2016) · Cardiovascular Pathology · doi:10.1016/j.carpath.2016.07.001 · Cited by 155
Mints, Y. Y., Doros, G. D., Berk, J. L., Connors, L. H., & Ruberg, F. L. (2018) · ESC Heart Failure · doi:10.1002/ehf2.12308 · Cited by 152
Self-citationConnors, L. H., Prokaeva, T. B., Lim, A., Théberge, R., Falk, R. H., Doros, G. D., Berg, A. M., Costello, C. E., O’Hara, C., Seldin, D. C., et al. (2009) · American Heart Journal · doi:10.1016/j.ahj.2009.08.006 · Cited by 151
Identification of TTR-Related Subclinical Amyloidosis With 99mTc-DPD Scintigraphy
Longhi, S., Guidalotti, P., Quarta, C. C., Gagliardi, C., Milandri, A., Lorenzini, M., Potena, L., Leone, O., Bartolomei, I., Pastorelli, F., et al. (2014) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2014.03.004 · Cited by 129
Sekijima, Y., Tojo, K., Morita, H., Koyama, J., & Ikeda, S. (2015) · Amyloid · doi:10.3109/13506129.2014.997872 · Cited by 128
99m Tc-DPD uptake reflects amyloid fibril composition in hereditary transthyretin amyloidosis
Pilebro, B., Suhr, O. B., Näslund, U., Westermark, P., Lindqvist, P., & Sundström, T. (2016) · Upsala Journal of Medical Sciences · doi:10.3109/03009734.2015.1122687 · Cited by 125
Evaluating the binding selectivity of transthyretin amyloid fibril inhibitors in blood plasma
Purkey, H. E., Dorrell, M. I., & Kelly, J. W. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.091431798 · Cited by 124
Self-citationLeft Ventricular Systolic Dysfunction Precipitated by Verapamil in Cardiac Amyloidosis
Pollak, A., & Falk, R. H. (1993) · CHEST Journal · doi:10.1378/chest.104.2.618 · Cited by 124
Amyloid seeding of transthyretin by ex vivo cardiac fibrils and its inhibition
Saelices, L., Chung, K., Lee, J. H., Cohn, W., Whitelegge, J. P., Benson, M. D., & Eisenberg, D. S. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1805131115 · Cited by 110
Dungu, J. N., Papadopoulou, S. A., Wykes, K., Mahmood, I., Marshall, J., Valencia, O., Fontana, M., Whelan, C. J., Gillmore, J. D., Hawkins, P. N., et al. (2016) · Circulation Heart Failure · doi:10.1161/circheartfailure.116.003352 · Cited by 105
Rosenblum, H., Castaño, A., Alvarez, J., Goldsmith, J., Helmke, S. T., & Maurer, M. S. (2018) · Circulation Heart Failure · doi:10.1161/circheartfailure.117.004769 · Cited by 103
Self-citationBhuiyan, T., Helmke, S. T., Patel, A. R., Ruberg, F. L., Packman, J., Cheung, K. N., Grogan, D. R., & Maurer, M. S. (2010) · Circulation Heart Failure · doi:10.1161/circheartfailure.109.910455 · Cited by 99
Self-citationNovel conformation-specific monoclonal antibodies against amyloidogenic forms of transthyretin
Higaki, J. N., Chakrabartty, A., Galant, N. J., Hadley, K. C., Hammerson, B., Nijjar, T., Torres, R., Tapia, J. R., Salmans, J., Barbour, R., et al. (2016) · Amyloid · doi:10.3109/13506129.2016.1148025 · Cited by 98
Transthyretin V122I in African Americans With Congestive Heart Failure
Buxbaum, J. N., Jacobson, D. R., Tagoe, C. E., Alexander, A. A., Kitzman, D. W., Greenberg, B., Thaneemit-Chen, S., & Lavori, P. W. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.01.042 · Cited by 92
Maurer, M. S., Elliot, P. M., Merlini, G., Shah, S. J., Waddington‐Cruz, M., Flynn, A., Gundapaneni, B. K., Hahn, C. M., Riley, S., Schwartz, J., et al. (2017) · Circulation Heart Failure · doi:10.1161/circheartfailure.116.003815 · Cited by 90
Self-citationBenson, M. D., Dasgupta, N. R., Rissing, S. M., Smith, J., & Feigenbaum, H. (2017) · Amyloid · doi:10.1080/13506129.2017.1374946 · Cited by 86
Diflunisal tolerability in transthyretin cardiac amyloidosis: a single center’s experience
Ikram, A., Donnelly, J. P., Sperry, B. W., Samaras, C. J., Valent, J. N., & Hanna, M. A. (2018) · Amyloid · doi:10.1080/13506129.2018.1519507 · Cited by 63
Self-citationDungu, J. N., Sattianayagam, P. T., Whelan, C. J., Gibbs, S. D., Pinney, J. H., Banypersad, S. M., Rowczenio, D. M., Gilbertson, J. A., Lachmann, H. J., Wechalekar, A. D., et al. (2012) · American Heart Journal · doi:10.1016/j.ahj.2012.04.013 · Cited by 60
Helder, M. R. K., Schaff, H. V., Nishimura, R. A., Gersh, B. J., Dearani, J. A., Ommen, S. R., Mereuta, O. M., Theis, J. D., Doǧan, A., & Edwards, W. D. (2014) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2014.07.058 · Cited by 43
Vollmar, J., Schmid, J. C., Hoppe‐Lotichius, M., Barreiros, A. P., Azizi, M., Emrich, T., Geber, C., Schad, A., Weyer, V., Otto, G., et al. (2018) · Transplant International · doi:10.1111/tri.13326 · Cited by 43
Galant, N. J., Bugyei‐Twum, A., Rakhit, R., Walsh, P. J., Sharpe, S. J., Arslan, P. E., Westermark, P., Higaki, J. N., Torres, R., Tapia, J. R., et al. (2016) · Scientific Reports · doi:10.1038/srep25080 · Cited by 37
Cited by
2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure
McDonagh, T. A., Metra, M., Adamo, M., Gardner, R. S., Baumbach, A., Böhm, M., Burri, H., Butler, J., Čelutkienė, J., Chioncel, O., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab368 · Cited by 13,344
Authors/Task Force Members:, McDonagh, T. A., Metra, M., Adamo, M., Gardner, R. S., Baumbach, A., Böhm, M., Burri, H., Butler, J., Čelutkienė, J., et al. (2022) · European Journal of Heart Failure · doi:10.1002/ejhf.2333 · Cited by 2,171
Garcia-Pavia, P., Rapezzi, C., Adler, Y., Arad, M., Basso, C., Brucato, A., Burazor, I., Caforio, A. L. P., Damy, T., Eriksson, U., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab072 · Cited by 1,231
Self-citationEpidemiology of Heart Failure: A Contemporary Perspective
Roger, V. L. (2021) · Circulation Research · doi:10.1161/circresaha.121.318172 · Cited by 946
Kittleson, M. M., Ruberg, F. L., Ambardekar, A. V., Brannagan, T. H., Cheng, R. K., Clarke, J. O., Dember, L. M., Frantz, J. G., Hershberger, R. E., Maurer, M. S., et al. (2023) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2022.11.022 · Cited by 640
Self-citation
Metadata
- Authors
- Ruberg, F. L., Grogan, M., Hanna, M., Kelly, J. W., & Maurer, M. S.
- Venue
- Journal of the American College of Cardiology
- Publisher
- Elsevier BV
- Published
- 2019-06
- Volume
- 73
- Issue
- 22
- Pages
- 2872-2891
- ISSN
- 0735-1097 (ISSN-L)
- OpenAlex
- W2948364217
- Cited by
- 1,112
- References
- 91
- FWCI
- 32.44
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.